FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← NTLA · Intellia Therapeutics, Inc.
DEFA14AThe Ballot

Intellia Therapeutics, Inc. files DEFA14A

Filed Apr 30, 2026 · 2mo ago · Accession 0001193125-26-197355

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Intellia Therapeutics, Inc.
Ticker
NTLA
CIK
1652130
Form type
DEFA14A
Filing date
Apr 30, 2026
Report date
—
Document
ntla_defa14a_2026.htm
Size
5.2 MB

More from NTLA

8-KReg FD Disclosure · Company UpdateJun 15, 20268-KShareholder VoteJun 10, 202610-QThe RecordMay 11, 20268-KResults of OperationsMay 11, 2026DEF 14AThe BallotApr 30, 20268-KMaterial Agreement · Results of OperationsApr 30, 2026